The Thai government has approved a price range of 500 million baht to buy provides of Pfizer’s antiviral treatment, Paxlovid. It’s understood the fund is part of the government’s 8.4-billion-baht pandemic budget. https://solarcellexperts.com/ has confirmed budgetary approval for the procurement of Paxlovid.The Bangkok Post reports that most of the government’s 8.4-billion-baht Covid-19 budget ? 7.7 billion baht ? is being allocated to frontline healthcare employees and medical staff attached to the public health secretariat office. Traisulee says the funds allocated to the purchase of Paxlovid will contribute to efforts to overcome the Covid-19 disaster in Thailand.<img width="449" src="https://solarcellexperts.com/wp-content/uploads/2023/07/W-EXTRA-%E0%B9%82%E0%B8%8B%E0%B8%A5%E0%B9%88%E0%B8%B2%E0%B9%80%E0%B8%8B%E0%B8%A5-01-1229x1536.jpg">Thailand has used various drugs in its attempts to deal with gentle Covid-19 symptoms, together with favipiravir, molnupiravir, remdesivir, and green chiretta. Last week, a leading medic from the Thai Red Cross Emerging Infectious Diseases Clinical Centre called for the usage of favipiravir to be phased out and changed with molnupiravir. According to Dr Opass Putcharoen, there is inadequate data to show the efficacy of favipiravir.SOURCE: Bangkok Post


トップ   編集 凍結 差分 バックアップ 添付 複製 名前変更 リロード   新規 一覧 単語検索 最終更新   ヘルプ   最終更新のRSS
Last-modified: 2023-09-12 (火) 23:51:22 (238d)